Crystallographic Structure of Human Dihydroorotate Dehydrogenase in Complex with the Natural Product Inhibitor Lapachol. [PDF]
Purificação AD +6 more
europepmc +1 more source
Biaryl Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML). [PDF]
Sabnis RW.
europepmc +1 more source
Crystal structure of dihydroorotate dehydrogenase from Helicobacter pylori with bound flavin mononucleotide. [PDF]
Agarwal AA +9 more
europepmc +1 more source
Molecular Dynamics Studies on <i>Trypanosoma cruzi</i> Dihydroorotate Dehydrogenase Complexes: An Analysis of the Inhibitor Influence. [PDF]
Santos EG +3 more
europepmc +1 more source
Heterocyclic Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML). [PDF]
Sabnis RW.
europepmc +1 more source
A phase 1, first-in-human, dose-escalation study of JNJ-74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS. [PDF]
Searle E +30 more
europepmc +1 more source
Selective vulnerability of human-induced pluripotent stem cells to dihydroorotate dehydrogenase inhibition during mesenchymal stem/stromal cell purification. [PDF]
Al-Akashi Z +5 more
europepmc +1 more source
On the interactions of leflunomide and teriflunomide within receptor cavity — NMR studies and energy calculations [PDF]
core +1 more source
Correction: Zhao et al. <i>Bombyx mori</i> Dihydroorotate Dehydrogenase: Knockdown Inhibits Cell Growth and Proliferation via Inducing Cell Cycle Arrest. <i>Int. J. Mol. Sci.</i> 2018, <i>19</i>, 2581. [PDF]
Zhao E, Jiang X, Cui H.
europepmc +1 more source
Discovery of potential natural dihydroorotate dehydrogenase inhibitors and their synergism with brequinar via integrated molecular docking, dynamic simulations and in vitro approach. [PDF]
Khairy A +4 more
europepmc +1 more source

